Treatment with LAT-1 inhibitor reduces mTOR signaling and attenuation of cyst growth indicated that LAT-1 inhibitor is a potential therapeutic agent for ADPKD (Yamamoto et al., 2017). This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.